Introduction of Ceftobiprole Medocaril Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10 Code History

Introduction of Mosunetuzumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 8 Code History

Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Cefepime-taniborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 10 Code History

Introduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10 Code History

Introduction of Durvalumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 6 Code History

Introduction of Nerinitide into Central Vein, Percutaneous Approach, New Technology Group 6 Code History

Introduction of Spesolimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 8 Code History

Introduction of Brexanolone into Central Vein, Percutaneous Approach, New Technology Group 6 Code History